We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bone Marrow Grafting for Leukemia and Lymphoma

This study is currently recruiting participants.
Verified November 2016 by Stanford University
Sponsor:
ClinicalTrials.gov Identifier:
NCT00186147
First Posted: September 16, 2005
Last Update Posted: November 9, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Stanford University
September 13, 2005
September 16, 2005
November 9, 2016
March 1988
December 2018   (Final data collection date for primary outcome measure)
Identify and characterize proteins and genes that may contribute to the development and progression of cancer. [ Time Frame: blood sample is collected prior transplant, periodically during the first three months and then indefinately at follow up ]
Not Provided
Complete list of historical versions of study NCT00186147 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Bone Marrow Grafting for Leukemia and Lymphoma
Bone Marrow Grafting for Leukemia and Lymphoma
The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.
The purpose of this study is to obtain tissue samples for ongoing studies regarding transplant outcomes and complications.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
Tissue samples will be obtained from subjects undergoing transplantation or donors providing the graft.
Non-Probability Sample
All hematopoietic cell transplant recipients and donors who agree to participate
  • Leukemia
  • Lymphoma
  • Hematologic Diseases
Procedure: collection and storage of tissue samples for research
Tissue samples include blood draws for the donor and recipient. A bone marrow sample may be obtained from the recipient. If the recipient undergoes a tissue biopsy for clinical reasons, a small fraction may be removed for research purposes. A small fraction of the donor graft may be removed at the time of collection for research.
Graft recipients and donors
Intervention: Procedure: collection and storage of tissue samples for research
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
9999
December 2019
December 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:- All hematopoietic cell transplant recipients and donors who agree to participate

Exclusion Criteria:- Subject does not agree to participate

Sexes Eligible for Study: All
up to 70 Years   (Child, Adult, Senior)
No
Contact: Physician Referrals (650) 723-0822
United States
 
 
NCT00186147
BMT19
13358
BMT19
Not Provided
Not Provided
Not Provided
Stanford University
Stanford University
  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)
Principal Investigator: David Miklos Stanford University
Principal Investigator: Robert S Negrin Stanford University
Stanford University
November 2016